Lucette Tablets

What Sets Lucette Apart

Lucette is a combined oral contraceptive tablet containing ethinylestradiol 30 micrograms and drospirenone 3 milligrams per tablet. It is licensed in the United Kingdom for the prevention of pregnancy. Lucette belongs to the combined hormonal contraceptive group of medicines. It works by suppressing ovulation and altering cervical mucus and the endometrial lining to prevent fertilisation and implantation. It is available as a film-coated tablet in a 28-tablet every-day format containing 21 active and 7 inactive placebo tablets. Lucette is the generic equivalent of Yasmin and is manufactured by Stragen UK Ltd. This page explains how Lucette works, how to take it, its unique drospirenone properties, and all important safety information.

What distinguishes Lucette from most combined pills on the market is the progestogen it uses. Drospirenone is derived from spironolactone, a compound with known anti-fluid and anti-androgen properties. No other progestogen used in UK-licensed combined pills carries this dual action. This means Lucette does something that standard progestogens cannot: it actively counteracts the fluid-retaining effects of oestrogen, rather than simply adding to them.

Lucette is a monophasic combined oral contraceptive, meaning every active tablet in the 28-tablet pack delivers exactly the same hormone dose. The pack contains:

1. 21 active tablets (yellow): ethinylestradiol 30 micrograms + drospirenone 3 milligrams per tablet
2. 7 inactive tablets (white): placebo tablets containing no hormones, taken daily to maintain the tablet-taking habit

Drospirenone is classified as a fourth-generation progestogen. It is the only progestogen used in UK licensed combined oral contraceptives that is structurally related to spironolactone. This structural relationship gives it two pharmacological properties absent from most other progestogens:

1. Anti-mineralocorticoid activity: drospirenone blocks aldosterone receptors, counteracting the sodium and fluid retention that oestrogen and some progestogens can cause. The net result for some women is reduced cyclical bloating and fluid-related weight fluctuation.
2. Anti-androgenic activity: drospirenone has a mild inhibitory effect on androgen receptors. This is why drospirenone-containing pills are sometimes considered by prescribers for women with hormonally influenced skin, although Lucette itself is not licensed for acne treatment.

Lucette is the generic equivalent of Yasmin. Both contain ethinylestradiol 30 micrograms and drospirenone 3 milligrams at identical doses and are considered clinically equivalent under FSRH and NHS prescribing guidance. The manufacturer differs: Lucette is made by Stragen UK Ltd; Yasmin is made by Bayer plc. If your pharmacy dispenses one in place of the other, the contraceptive content is unchanged.

Step One: Switching Off the Ovulation Signal

Ethinylestradiol and drospirenone act jointly on the pituitary gland to suppress follicle-stimulating hormone and luteinising hormone. The luteinising hormone surge is what normally triggers egg release. Suppress that surge and the ovary has no signal to act on. No egg is released. No fertilisation is possible. This is the primary and dominant mechanism of Lucette, as it is for all combined pills.

Step Two: Closing the Cervical Gate

Drospirenone thickens the cervical mucus, making it significantly more resistant to sperm penetration. Even in the unlikely event of reduced ovulation suppression on a given cycle, sperm would face a hostile biochemical barrier before reaching the uterus.

Step Three: Altering the Uterine Environment

The combined hormonal effect also changes the endometrial lining, reducing its readiness for implantation. This is a third layer of contraceptive protection. In practice, ovulation suppression is so consistent that this third mechanism is rarely relevant, but it forms part of the comprehensive contraceptive action.

What Drospirenone Does That Other Progestogens Cannot

Most synthetic progestogens add to the body's fluid-retaining hormonal environment. Drospirenone does the opposite. By blocking aldosterone receptors, it reduces sodium retention and the fluid accumulation that often accompanies oestrogen and some progestogens. Clinical studies have shown that some women on drospirenone-containing pills report less cyclical bloating than on preparations using older progestogens. This is not guaranteed, and individual responses vary, but it is a clinically documented property unique to drospirenone.

The Withdrawal Bleed on Lucette

After 21 active tablets, the 7 inactive tablets allow oestrogen and drospirenone levels to fall. This hormone withdrawal triggers a bleed during the inactive tablet days. The bleed is not a menstrual period in the traditional sense. It is pharmacologically induced by the hormone drop and is typically lighter, shorter, and more predictable than a natural period.

Getting Started

1. Day 1 of your period: begin with the first yellow active tablet. Protection is immediate.
2. Days 2 to 5 of your period: you can start within the first five days of bleeding. Use condoms or another barrier method for the first seven days.
3. Switching from another combined pill: take your first Lucette active tablet the day after the last active tablet from the previous pack, or the day after the final inactive tablet if your previous pill also had placebo days. No gap needed; protection is continuous.
4. Switching from a progestogen-only pill: start Lucette on any day of the cycle. Use a barrier method for the first seven days.

The 28-Day Routine

Lucette is an every-day pill. There is no break between packs. Take one tablet daily in order: 21 yellow active tablets, then 7 white inactive tablets, then immediately start the next pack on day 29.

1. Take each tablet at the same time every day. Consistent timing is the simplest way to maintain reliable hormone levels.
2. The white inactive tablets are there so you always have something to take, even during the hormone-free phase.
3. A withdrawal bleed will usually start during the inactive tablet days. Continue taking your tablets as normal throughout the bleed.
4. If you vomit within two hours of taking an active tablet, or experience severe diarrhoea, absorption may be incomplete. Treat this as a missed active tablet.

If You Miss a Tablet

The rules differ depending on whether the missed tablet is active or inactive:

1. Missed a white inactive tablet: discard it and carry on. Your contraceptive protection is not affected.
2. Missed one yellow active tablet, under 24 hours late: take it as soon as you remember and continue the pack. You remain protected.
3. Missed one yellow active tablet, over 24 hours late: take the missed tablet now, take the next one at the usual time (two in one day is acceptable), and use a barrier method for the next seven days.
4. Missed two or more yellow active tablets in a row: take only the most recently missed one, discard the rest, continue the pack in order, and use barrier contraception for seven days. If missed active tablets fell in week one of the pack and you had unprotected sex during that window, contact your prescriber or pharmacist urgently about emergency contraception.

Per-Tablet Composition

1. Active tablets (21): ethinylestradiol 30 micrograms + drospirenone 3 milligrams
2. Inactive tablets (7): lactose-based placebo; no hormones
3. Monophasic: identical active dose in every yellow tablet

The Every-Day Format Explained

Unlike standard combined pills that use a 21-day active pack followed by a seven-day break with no tablets, Lucette keeps you taking a tablet every single day. The seven inactive tablets replace the break. Clinically, the effect is the same: hormone levels fall, a withdrawal bleed occurs, and the next active course begins seamlessly. The practical difference is that there is no day-counting, no restart reminder, and no break to forget to end.

Lucette and Yasmin: Clinical Equivalence

Lucette and Yasmin are clinically equivalent. They contain the same active ingredients at the same doses, use the same 21-active-plus-7-inactive format, and follow the same prescribing criteria. The manufacturer differs: Stragen UK produces Lucette; Bayer produces Yasmin. Women previously prescribed Yasmin who receive Lucette are getting the same contraceptive in a different box.

Note on Potassium: A Clinically Important Detail

Drospirenone's anti-mineralocorticoid action affects the body's handling of potassium. In healthy women with normal kidney function, this has no clinical consequences. However, if you regularly take other medicines that raise potassium levels, including ACE inhibitors, angiotensin II receptor antagonists, spironolactone, potassium-sparing diuretics, NSAIDs, or heparin, there is a risk that potassium levels could rise to a harmful level. This is why renal insufficiency and adrenal insufficiency are specific contraindications to Lucette that do not apply to most other combined pills. Your prescriber will screen for this during your consultation.

Clinical note: Drospirenone can raise serum potassium. If you take potassium-raising medicines, tell your prescriber before starting Lucette. Renal and adrenal insufficiency are absolute contraindications to this preparation.

The following is based on the current UK SmPC for Lucette. Not every woman will experience side effects. Individual responses vary. Read the Patient Information Leaflet in full before starting.

Common Side Effects

• Headache or migraine
• Nausea, more frequent in the first few weeks
• Breast tenderness or discomfort
• Mood changes, including low mood or irritability
• Changes in libido
• Irregular spotting in the first one to three cycles
• Changes in vaginal discharge

Less Common Side Effects

• Weight changes
• Contact lens intolerance due to changes in corneal curvature
• Chloasma: patches of darker skin on the face, worsened by sun exposure

Serious Side Effects: Seek Urgent Help Without Delay If You Notice

• Sudden chest pain, breathlessness, or coughing up blood: possible clot in the lungs or heart attack.
• Pain, swelling, redness, or warmth in one leg only: possible deep vein thrombosis.
• Sudden severe headache, speech difficulty, loss of vision, or one-sided weakness: possible stroke.
• Acute severe abdominal pain: possible liver complication or ectopic pregnancy.
• Yellow skin or eyes: possible jaundice or liver dysfunction.

Blood Clot Risk

All combined oral contraceptives raise VTE risk above the baseline for women using no hormonal contraception. Drospirenone-containing pills including Lucette carry a somewhat higher VTE risk than levonorgestrel-containing pills, and a broadly similar risk to other third-generation combined pills. This is confirmed in MHRA guidance. Your prescriber weighs your individual risk factors: BMI, smoking, personal and family history of blood clots, and planned immobility. These factors, not the pill choice alone, determine your personal risk level.

Medicines That Interact With Lucette

Enzyme-inducing medicines accelerate the breakdown of ethinylestradiol and drospirenone, reducing their blood levels and contraceptive reliability:

• Rifampicin and rifabutin
• Antiepileptic medicines: phenytoin, carbamazepine, phenobarbital, primidone, topiramate
• HIV antiretrovirals: ritonavir, efavirenz, and others
• St John's Wort, available without prescription in pharmacies and health food stores

Also declare: potassium-raising medicines listed in the dosage section above. Disclose every medicine, supplement, and herbal product at every consultation.

Lucette Is Not Suitable If You:

• Have ever had a blood clot: DVT, pulmonary embolism, stroke, or heart attack
• Experience migraine with aura: an absolute contraindication to all oestrogen-containing combined pills regardless of progestogen
• Have uncontrolled high blood pressure
• Have renal insufficiency or adrenal insufficiency: specific contraindications due to drospirenone's potassium-raising mechanism
• Have active or past liver disease, liver tumours, or pill-related jaundice
• Have a current or previous diagnosis of breast cancer or a hormone-sensitive malignancy
• Are pregnant or think you may be
• Are breastfeeding a baby under six weeks of age
• Smoke and are aged 35 or older
• Have diabetes with established vascular complications

Lucette May Be Appropriate If You:

• Are a healthy adult woman with no contraindications to combined hormonal contraception
• Have normal kidney function and are not taking potassium-raising medicines
• Prefer an every-day pill format with no break period to manage
• Were previously prescribed Yasmin and are being dispensed Lucette as its generic equivalent
• Have no personal or family history of blood clots, stroke, or cardiovascular disease

Discuss With Your Prescriber Before Starting If You:

• Smoke and are under 35. Smoking at any age raises cardiovascular risk with oestrogen-containing contraception.
• Have a BMI above 30. Raised BMI is an independent VTE risk factor.
• Have a first-degree relative who had a blood clot before the age of 50.
• Experience migraine without aura. Individual clinical assessment is required before any combined pill is prescribed.
• Take any medicines that affect potassium levels.
• Are planning long-haul travel or face extended immobility in the near term.
• Have a history of depression or are currently receiving treatment for a mood disorder.

Pharmacy Planet is a GPhC registered UK online pharmacy. Prescriptions for Lucette are issued following individual clinical consultations reviewed by registered prescribers. Because Lucette contains drospirenone, the prescriber's assessment includes a specific check for renal function, adrenal health, and any co-prescribed medicines that raise potassium. This is not a routine check required for most combined pills; it is specific to drospirenone-based preparations.

You complete a clinical questionnaire. The prescriber reads every response individually and makes a clinical decision. The outcome may be a prescription for Lucette, a recommendation for an alternative combined pill without the drospirenone-potassium consideration, a different contraceptive method, a request for more information, or a referral for face-to-face review. Completing a questionnaire is the first step in the clinical process. It does not guarantee a prescription. Repeat supply prescriptions follow the same individual review with no automatic renewal.

• Store below 25°C. Avoid windowsills, cars, and bathrooms where heat and humidity fluctuate.
• Keep tablets in the original blister strip. The yellow and white colour coding tells you which tablets are active and which are inactive.
• Store out of reach and sight of children at all times.
• Check the expiry date on the outer carton before use. Discard expired packs.
• Return unused or out-of-date tablets to any UK pharmacy for safe disposal at no charge. Do not flush tablets or put them in household rubbish.

This reference guide compares the contraceptive preparations available at Pharmacy Planet, grouped by delivery method and formulation type. Every preparation is a Prescription Only Medicine. A registered prescriber will review your individual health profile, contraceptive history, and risk factors before recommending any preparation. This table is a clinical reference, not a recommendation.

Combined Oral Contraceptive Tablets (Monophasic)

Monophasic combined pills contain the same dose of both hormones in every active tablet. The table below compares commonly prescribed monophasic combined oral contraceptives by progestogen type, oestrogen dose, VTE risk category, pack format, and key clinical characteristics.

Important: This comparison is for general information only and does not replace medical advice. A prescriber will decide which treatment is suitable for you following an online consultation.

Lucette is not simply another combined pill. The drospirenone it contains requires a prescriber to think beyond the standard combined pill checklist. Potassium-raising co-medications, renal function, and adrenal health all become relevant clinical considerations the moment drospirenone enters the picture. At Pharmacy Planet, our prescribers are equipped to work through that assessment thoroughly for every consultation, not as a formality but as a genuine clinical evaluation.

If Lucette is not appropriate for your health profile, the prescriber will tell you so and explain why. They may suggest an alternative drospirenone-free pill, a non-hormonal option, or an in-person review. That is what a responsible prescribing service does. We do not optimise for speed of supply; we optimise for clinical accuracy.

Our GPhC registration is verifiable at www.pharmacyregulation.org. The Internet Pharmacy logo on our site confirms our standing as a legitimate, regulated UK online pharmacy. Our pharmacy team is available at every stage of the process.

• Stragen UK Ltd. Lucette 0.03 mg/3 mg film-coated tablets – Summary of Product Characteristics. Available at: www.medicines.org.uk/emc. Accessed May 2026.
• Faculty of Sexual and Reproductive Healthcare (FSRH). Combined Hormonal Contraception – Clinical Guidance. Available at: www.fsrh.org. Accessed May 2026.
• NHS, Combined pill – your contraception guide. Available at: www.nhs.uk/conditions/contraception/combined-contraceptive-pill. Accessed May 2026.
• British National Formulary (BNF). Ethinylestradiol with drospirenone. Available at: bnf.nice.org.uk. Accessed May 2026.
• MHRA. Combined hormonal contraceptives and venous thromboembolism – updated guidance. Available at: www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency. Accessed May 2026.